Press Release: Epicrispr Biotechnologies Partners with Springbok Analytics to Integrate AI Muscle Analysis in First-in-Human FSHD Study
[…] its first-in-human clinical trial of EPI-321, a potential first-in-class treatment for facioscapulohumeral muscular dystrophy ( FSHD). The exploratory first-in-human global trial, recently cleared to begin in the United States and […]